Brand Name: Vronogabic 150mg Capsule
Vronogabic 75 mg Caspule
Active Ingredient: Pregabalin
When is Vronogabic Capsule prescribed for?
- Management of neuropathic pain associated with diabetic peripheral neuropathy.
- Management of post herpetic neuralgia.
- Adjunctive therapy for adult patients with partial onset seizures.
- Management of fibromyalgia.
How should you take Vronogabic Capsule?
Recommended effective dose:
1 capsule 75mg b.i.d
Increased after 3 to 7 days interval to 1 capsule 150mg b.i.d based on individual patient response
When you should not take Vronogabic Capsule?
Hypersensitivity to the active substance or to any of the excipients.
Special warning and precautions on using Vronogabic Capsule:
Renal impairment: Because renal elimination is the major elimination pathway, dosage reduction in patients with renal impairment and dosage supplementation following haemodialysis is necessary.
Possible Drug interaction with Vronogabic Capsule:
- In vivo studies no clinically relevant pharmacokinetic interactions were observed between pregabalin and other AEDs, lorazepam, oxycodone or ethanol.
- Population pharmacokinetic analysis indicated that oral antidiabetics, diuretics, insulin, phenobarbital, tiagabine and topiramate had no clinically significant effect on pregabalin clearance
- No clinically significant drug-drug interaction with the oral contraceptives norethisterone and/or ethinyl oestradiol.
Special information if you are pregnant or breastfeeding
Pregnancy
There are no adequate data from the use of pregabalin in pregnant women.
Lactation
Breast-feeding is not recommended during treatment with pregabalin
Possible Side effects of Vronogabic Capsule
- Dizziness
- Somnolence